FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510158554> ?p ?o ?g. }

• W2510158554 endingPage "938" @default.
• W2510158554 startingPage "934" @default.
• W2510158554 abstract "Since the 1988 World Health Assembly resolution to eradicate poliomyelitis, transmission of the three types of wild poliovirus (WPV) has been sharply reduced (1). WPV type 2 (WPV2) has not been detected since 1999 and was declared eradicated in September 2015. Because WPV type 3 has not been detected since November 2012, WPV type 1 (WPV1) is likely the only WPV that remains in circulation (1). This marked progress has been achieved through widespread use of oral poliovirus vaccines (OPVs), most commonly trivalent OPV (tOPV), which contains types 1, 2, and 3 live, attenuated polioviruses and has been a mainstay of efforts to prevent polio since the early 1960s. However, attenuated polioviruses in OPV can undergo genetic changes during replication, and in communities with low vaccination coverage, can result in vaccine-derived polioviruses (VDPVs) that can cause paralytic polio indistinguishable from the disease caused by WPVs (2). Among the 721 polio cases caused by circulating VDPVs (cVDPVs*) detected during January 2006-May 2016, type 2 cVDPVs (cVDPV2s) accounted for >94% (2). Eliminating the risk for polio caused by VDPVs will require stopping all OPV use. The first stage of OPV withdrawal involved a global, synchronized replacement of tOPV with bivalent OPV (bOPV) containing only types 1 and 3 attenuated polioviruses, planned for April 18-May 1, 2016, thereby withdrawing OPV type 2 from all immunization activities (3). Complementing the switch from tOPV to bOPV, introduction of at least 1 dose of injectable, trivalent inactivated poliovirus vaccine (IPV) into childhood immunization schedules reduces risks from and facilitates responses to cVDPV2 outbreaks. All 155 countries and territories that were still using OPV in immunization schedules in 2015 have reported that they had ceased use of tOPV by mid-May 2016.(†) As of August 31, 2016, 173 (89%) of 194 World Health Organization (WHO) countries included IPV in their immunization schedules.(§) The cessation of tOPV use is a major milestone toward the global goal of eradicating polio; however, careful surveillance for polioviruses and prompt, aggressive responses to polio outbreaks are still needed to realize a polio-free world." @default.
• W2510158554 created "2016-09-16" @default.
• W2510158554 creator A5005599427 @default.
• W2510158554 creator A5027712050 @default.
• W2510158554 creator A5032715032 @default.
• W2510158554 creator A5034577663 @default.
• W2510158554 creator A5036800130 @default.
• W2510158554 creator A5037076331 @default.
• W2510158554 creator A5043317582 @default.
• W2510158554 creator A5047491917 @default.
• W2510158554 creator A5052959733 @default.
• W2510158554 creator A5071795775 @default.
• W2510158554 creator A5080269302 @default.
• W2510158554 creator A5087750390 @default.
• W2510158554 creator A5090044059 @default.
• W2510158554 creator A5091877975 @default.
• W2510158554 date "2016-09-09" @default.
• W2510158554 modified "2023-10-17" @default.
• W2510158554 title "Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine — Worldwide, 2016" @default.
• W2510158554 cites W141065489 @default.
• W2510158554 cites W2364126779 @default.
• W2510158554 cites W2397702549 @default.
• W2510158554 cites W2414307035 @default.
• W2510158554 cites W2414892767 @default.
• W2510158554 cites W2505145267 @default.
• W2510158554 cites W4251332709 @default.
• W2510158554 doi "https://doi.org/10.15585/mmwr.mm6535a3" @default.
• W2510158554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27606675" @default.
• W2510158554 hasPublicationYear "2016" @default.
• W2510158554 type Work @default.
• W2510158554 sameAs 2510158554 @default.
• W2510158554 citedByCount "151" @default.
• W2510158554 countsByYear W25101585542016 @default.
• W2510158554 countsByYear W25101585542017 @default.
• W2510158554 countsByYear W25101585542018 @default.
• W2510158554 countsByYear W25101585542019 @default.
• W2510158554 countsByYear W25101585542020 @default.
• W2510158554 countsByYear W25101585542021 @default.
• W2510158554 countsByYear W25101585542022 @default.
• W2510158554 countsByYear W25101585542023 @default.
• W2510158554 crossrefType "journal-article" @default.
• W2510158554 hasAuthorship W2510158554A5005599427 @default.
• W2510158554 hasAuthorship W2510158554A5027712050 @default.
• W2510158554 hasAuthorship W2510158554A5032715032 @default.
• W2510158554 hasAuthorship W2510158554A5034577663 @default.
• W2510158554 hasAuthorship W2510158554A5036800130 @default.
• W2510158554 hasAuthorship W2510158554A5037076331 @default.
• W2510158554 hasAuthorship W2510158554A5043317582 @default.
• W2510158554 hasAuthorship W2510158554A5047491917 @default.
• W2510158554 hasAuthorship W2510158554A5052959733 @default.
• W2510158554 hasAuthorship W2510158554A5071795775 @default.
• W2510158554 hasAuthorship W2510158554A5080269302 @default.
• W2510158554 hasAuthorship W2510158554A5087750390 @default.
• W2510158554 hasAuthorship W2510158554A5090044059 @default.
• W2510158554 hasAuthorship W2510158554A5091877975 @default.
• W2510158554 hasBestOaLocation W25101585541 @default.
• W2510158554 hasConcept C126322002 @default.
• W2510158554 hasConcept C151492266 @default.
• W2510158554 hasConcept C159047783 @default.
• W2510158554 hasConcept C159654299 @default.
• W2510158554 hasConcept C203014093 @default.
• W2510158554 hasConcept C22070199 @default.
• W2510158554 hasConcept C2522874641 @default.
• W2510158554 hasConcept C2779134260 @default.
• W2510158554 hasConcept C2779631682 @default.
• W2510158554 hasConcept C2780801004 @default.
• W2510158554 hasConcept C2908689829 @default.
• W2510158554 hasConcept C2909513299 @default.
• W2510158554 hasConcept C2909656726 @default.
• W2510158554 hasConcept C4870876 @default.
• W2510158554 hasConcept C71924100 @default.
• W2510158554 hasConcept C99454951 @default.
• W2510158554 hasConceptScore W2510158554C126322002 @default.
• W2510158554 hasConceptScore W2510158554C151492266 @default.
• W2510158554 hasConceptScore W2510158554C159047783 @default.
• W2510158554 hasConceptScore W2510158554C159654299 @default.
• W2510158554 hasConceptScore W2510158554C203014093 @default.
• W2510158554 hasConceptScore W2510158554C22070199 @default.
• W2510158554 hasConceptScore W2510158554C2522874641 @default.
• W2510158554 hasConceptScore W2510158554C2779134260 @default.
• W2510158554 hasConceptScore W2510158554C2779631682 @default.
• W2510158554 hasConceptScore W2510158554C2780801004 @default.
• W2510158554 hasConceptScore W2510158554C2908689829 @default.
• W2510158554 hasConceptScore W2510158554C2909513299 @default.
• W2510158554 hasConceptScore W2510158554C2909656726 @default.
• W2510158554 hasConceptScore W2510158554C4870876 @default.
• W2510158554 hasConceptScore W2510158554C71924100 @default.
• W2510158554 hasConceptScore W2510158554C99454951 @default.
• W2510158554 hasIssue "35" @default.
• W2510158554 hasLocation W25101585541 @default.
• W2510158554 hasLocation W25101585542 @default.
• W2510158554 hasOpenAccess W2510158554 @default.
• W2510158554 hasPrimaryLocation W25101585541 @default.
• W2510158554 hasRelatedWork W1977580312 @default.
• W2510158554 hasRelatedWork W1986341366 @default.
• W2510158554 hasRelatedWork W2052637322 @default.
• W2510158554 hasRelatedWork W2064289900 @default.
• W2510158554 hasRelatedWork W2112959654 @default.

• next